Collectively, these findings underscore the central role of RAS/MAPK signaling in HCC pathogenesis and highlight multiple nodes—including RAF, MEK, ERK, adaptor proteins, and regulators—that represent viable targets for therapeutic intervention (Table 2). The gene discussed is RAF1; the disease is hepatocellular carcinoma.